PharmaShots Magazine - July 2023 Edition
Last month, PharmaShots was all about the infusion of cutting-edge technological advances into the life science industry. Our most read Top 20 covered Diagnostic Companies based on the total revenue in 2022 and Top 20 Nutraceutical Companies based on 2022 segment revenue. PharmaShots, like every month presented a detailed report on its informative disease of the month section covering Scleroderma. Our report on the Product of the month navigated through one of the Top-performing drugs Enbrel. Like every month PharmaShots acquainted its readers with key biosimilar development, FDA & EMA approvals
PharmaShots’ ThoughtSpot section featured a comprehensive article on the use of Intelligent Automation in Pharmaceutical Industry and covered the new Pilot program launched by FDA to regulate LDTs used to develop cancer biomarkers. ThoughtSpot also featured two guest posts on Revolutionizing Life Insurance & Multichannel Marketing Tactics in Pharma.
In associations with Agilent Technologies, PharmaShots hosted a webinar on Levelling up Lab Skills.
Get a chance to be featured in our magazine! Submit your white papers, advertisements, and interviews by reaching out to us at connect@pharmashots.com
Aditya brings a wealth of knowledge and expertise to Pharmashots, having spent his career at top-tier knowledge research and consulting firms. He has a proven track record of success in collaborating with a diverse range of clients, including leading global pharmaceutical and biotechnology companies. As Editor-in-Chief of Pharmashots, Aditya leverages his deep understanding of the life sciences landscape to curate insightful and impactful content, ensuring readers stay informed about the latest advancements in pharmaceuticals, biotechnology, MedTech, digital health, and the broader life sciences industry. Connect with Aditya on LinkedIn to stay up-to-date on the latest industry trends and insights.
